Ligand validation:6TT4

FT8: Omapatrilat

FT8 is a Ligand Of Interest in 6TT4 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6TT4_FT8_A_709	86%	17%	0.09	0.957	2.39	1.24	3	3	0	0	100%	1
6TT4_FT8_B_711	79%	18%	0.108	0.954	2.25	1.33	5	4	0	0	100%	1
6H5X_FT8_A_709	80%	19%	0.115	0.963	2.2	1.31	6	5	0	0	100%	1
6H5W_FT8_A_710	91%	22%	0.087	0.975	1.79	1.45	3	4	0	0	100%	1
6SUK_FT8_A_806	60%	11%	0.12	0.905	2.62	1.6	6	7	0	0	100%	0.966

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.